Evidence map›Paper›PMID 34409894›Full record

ReviewAnnals of medicine2021

The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Jin Zhang, Cheng Li, Xiaorong Han, Zhongbo Chen, Binay Kumar Adhikari, Yinghui Wang, Yonggang Wang, Jian Sun

Open access · goldAbstract readReview
In one paragraph

Review in Annals of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jin ZhangDepartment of Cardiovascular Center, Jilin University First Hospital, Changchun, China.
Cheng LiDepartment of Cardiovascular Center, Jilin University First Hospital, Changchun, China.
Xiaorong HanDepartment of Cardiovascular Center, Jilin University First Hospital, Changchun, China.
Zhongbo ChenDepartment of Cardiovascular Center, Jilin University First Hospital, Changchun, China.
Binay Kumar AdhikariDepartment of Medicine, Nepal Armed Police Force Command and Staff hospital, Kathmandu, Nepal.
Yinghui WangDepartment of Cardiovascular Center, Jilin University First Hospital, Changchun, China.
Yonggang WangDepartment of Cardiovascular Center, Jilin University First Hospital, Changchun, China.
Jian SunDepartment of Cardiovascular Center, Jilin University First Hospital, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CNPolice General Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease mainly characterised by vascular thrombosis and pregnancy morbidity. APS has broad spectrum of clinical manifestations. The digestive system involvement of antiphospholipid syndrome is a critical but under-recognised condition. Digestive system involvement may be the result of direct (autoimmune-mediated) or indirect (thrombotic) mechanisms. Liver is the most commonly involved organ, followed by intestines, oesophagus, stomach, pancreas and spleen. This review describes possible digestive system manifestations in APS patients, and illustrates the epidemiology and possible pathophysiology of APS. The role of different treatment strategies in the management of digestive system manifestations of APS were also discussed.Key messagesAntiphospholipid syndrome is a multi-organ, multi-system disease and its clinical manifestation spectrum is gradually expanding. Since the first diagnosis of APS, the clinical manifestations of digestive system have been reported successively. This narrative review describes the major digestive system manifestations of APS and illustrates the epidemiology, pathophysiology and the role of therapeutic strategies of these patients.

Indexed as

Antibodies, AntiphospholipidAntiphospholipid SyndromeAutoimmune DiseasesDigestive SystemFemaleHumansPregnancyThrombosisAntibodies, Antiphospholipidantiphospholipid antibodiesAntiphospholipid syndromeautoimmunedigestive systemthrombosis

Identifiers

PMID34409894
PMCPMC8381908
OpenAlexW3195718086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.